Stephen F. Betz is CSO at Crinetics Pharmaceuticals, Inc. (CRNX). They have made 29 open-market trades across 1 company since 2021, most recently 2026-03-16.
CIK 0001886575
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 29 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CRNX | 137,101 | $11.7M |
Shares reported on the most recent Form 4, priced at the 2026-03-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRNX | SELL · 10b5-1 | 2026-03-16 | 2026-03-18 | $37.37 | $397K | -4.0% | +14.8% | -1.8% |
| CRNX | SELL · 10b5-1 | 2025-06-12 | 2025-06-16 | $32.23 | $6.3M | -2.5% | +3.8% | +9.9% |
| CRNX | SELL · 10b5-1 | 2025-03-19 | 2025-03-21 | $34.19 | $385K | -9.3% | -12.9% | -12.9% |
| CRNX | SELL · 10b5-1 | 2024-09-10 | 2024-09-12 | $51.50 | $107K | -4.2% | +2.1% | +15.7% |
| CRNX | SELL · 10b5-1 | 2024-08-26 | 2024-08-28 | $53.19 | $160K | -7.6% | -7.0% | +4.0% |
| CRNX | SELL · 10b5-1 | 2024-08-12 | 2024-08-14 | $47.68 | $143K | +1.3% | +2.6% | +12.1% |
| CRNX | SELL · 10b5-1 | 2024-07-25 | 2024-07-26 | $53.43 | $160K | -11.3% | -2.4% | +7.9% |
| CRNX | SELL · 10b5-1 | 2024-07-10 | 2024-07-12 | $48.55 | $146K | +0.0% | -7.2% | -3.0% |
| CRNX | SELL · 10b5-1 | 2024-06-25 | 2024-06-26 | $45.37 | $136K | +14.1% | +28.6% | +17.9% |
| CRNX | SELL · 10b5-1 | 2024-06-10 | 2024-06-11 | $43.86 | $132K | -1.4% | +14.0% | +12.8% |
| CRNX | SELL · 10b5-1 | 2024-05-28 | 2024-05-30 | $47.49 | $142K | -1.9% | +0.8% | +19.1% |
| CRNX | SELL · 10b5-1 | 2024-05-10 | 2024-05-14 | $49.43 | $148K | -5.7% | -6.8% | -1.5% |
| CRNX | SELL · 10b5-1 | 2024-01-25 | 2024-01-26 | $37.26 | $112K | +1.8% | +4.2% | +14.0% |
| CRNX | SELL · 10b5-1 | 2024-01-10 | 2024-01-12 | $37.65 | $113K | -1.1% | +4.4% | +27.6% |
| CRNX | SELL · 10b5-1 | 2023-12-26 | 2023-12-27 | $35.89 | $108K | +4.6% | +2.6% | +19.7% |
| CRNX | SELL · 10b5-1 | 2023-12-11 | 2023-12-13 | $32.87 | $197K | +3.2% | +6.3% | +16.4% |
| CRNX | SELL · 10b5-1 | 2023-11-27 | 2023-11-29 | $31.84 | $96K | +3.0% | +11.0% | +26.3% |
| CRNX | SELL | 2023-02-01 | 2023-02-03 | $19.59 | $122K | +0.3% | -5.3% | +7.3% |
| CRNX | SELL | 2023-01-25 | 2023-01-27 | $21.07 | $351K | +0.4% | -4.9% | -7.6% |
| CRNX | SELL | 2023-01-17 | 2023-01-19 | $18.00 | $56K | +1.2% | +1.7% | -12.6% |
| CRNX | SELL | 2023-01-03 | 2023-01-05 | $18.35 | $115K | +7.6% | +15.3% | -8.6% |
| CRNX | SELL | 2022-12-15 | 2022-12-19 | $16.00 | $50K | +19.1% | +22.3% | +9.6% |
| CRNX | SELL | 2022-12-01 | 2022-12-05 | $17.84 | $112K | -10.6% | -4.3% | +3.9% |
| CRNX | SELL | 2022-11-15 | 2022-11-17 | $18.72 | $117K | -0.7% | -13.9% | +10.9% |
| CRNX | SELL | 2022-11-01 | 2022-11-03 | $18.52 | $116K | -0.8% | -0.4% | +8.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.